Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Newborn With Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)
Phase of Trial: Phase II
Latest Information Update: 07 Sep 2018
At a glance
- Drugs Propranolol (Primary)
- Indications Retinopathy of prematurity
- Focus Pharmacokinetics; Therapeutic Use
- 29 Aug 2018 Status changed from recruiting to completed.
- 10 Jan 2018 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.
- 10 Jan 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.